Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Tah noted animal studies indicating decreased eosinophilic infiltration and decreased airway inflammation with GLP-1 receptor agonists, which prompted her study
China has now approved GLP-1 therapies from Eli Lilly (Mounjaro), Innovent Biologics (mazdutide), and Guangzhou Innogen (efsubaglutide alfa), in addition to Xianyida
& Hirschi, K
Choi SY, Lee Y, Yu HE, Cho IJ, Kang M, Lee SY (2023) Sustainable production and degradation of plastics using microbes
et al., Biomedicines, 2022
Data availability The data generated in this study are available from the corresponding author upon reasonable request
US$ 28.18
US$ 22.39
US$ 23.46
US$ 26.96
US$ 29.54
